[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe OTC Drug Market Research Report Forecast 2017-2021

June 2017 | 137 pages | ID: E0F07A7A02FEN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Europe OTC Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the OTC Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This OTC Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
Europe OTC Drug Market Analysis by Countries:

Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:

Bayer HealthCare
GlaxoSmithKline (GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica

Europe OTC Drug Market Analysis by Product
  • Type 1
  • Type 2
  • Type 3
Europe OTC Drug Market Analysis by Application
  • Application 1
  • Application 2
  • Application 3
Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
1 OTC DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of OTC Drug
1.2 Classification of OTC Drug
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of OTC Drug
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 OTC Drug Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of OTC Drug (2012-2021)
  1.5.1 Europe OTC Drug Sales and Growth Rate (2012-2021)
  1.5.2 Europe OTC Drug Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON OTC DRUG INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 OTC DRUG MANUFACTURING COST ANALYSIS

3.1 OTC Drug Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of OTC Drug

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 OTC Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE OTC DRUG MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe OTC Drug Market Competition by Manufacturers
  5.1.1 Europe OTC Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe OTC Drug Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe OTC Drug (Volume and Value) by Type
  5.2.1 Europe OTC Drug Sales and Market Share by Type (2012-2017)
  5.2.2 Europe OTC Drug Revenue and Market Share by Type (2012-2017)
5.3 Europe OTC Drug (Volume and Value) by Countries
  5.3.1 Europe OTC Drug Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe OTC Drug Revenue and Market Share by Countries (2012-2017)
5.4 Europe OTC Drug (Volume) by Application

6 GERMANY OTC DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Germany OTC Drug Sales and Value (2012-2017)
  6.1.1 Germany OTC Drug Sales and Growth Rate (2012-2017)
  6.1.2 Germany OTC Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Germany OTC Drug Sales Price Trend (2012-2017)
6.2 Germany OTC Drug Sales and Market Share by Manufacturers
6.3 Germany OTC Drug Sales and Market Share by Type
6.4 Germany OTC Drug Sales and Market Share by Application

7 FRANCE OTC DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 France OTC Drug Sales and Value (2012-2017)
  7.1.1 France OTC Drug Sales and Growth Rate (2012-2017)
  7.1.2 France OTC Drug Revenue and Growth Rate (2012-2017)
  7.1.3 France OTC Drug Sales Price Trend (2012-2017)
7.2 France OTC Drug Sales and Market Share by Manufacturers
7.3 France OTC Drug Sales and Market Share by Type
7.4 France OTC Drug Sales and Market Share by Application

8 UK OTC DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 UK OTC Drug Sales and Value (2012-2017)
  8.1.1 UK OTC Drug Sales and Growth Rate (2012-2017)
  8.1.2 UK OTC Drug Revenue and Growth Rate (2012-2017)
  8.1.3 UK OTC Drug Sales Price Trend (2012-2017)
8.2 UK OTC Drug Sales and Market Share by Manufacturers
8.3 UK OTC Drug Sales and Market Share by Type
8.4 UK OTC Drug Sales and Market Share by Application

9 RUSSIA OTC DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Russia OTC Drug Sales and Value (2012-2017)
  9.1.1 Russia OTC Drug Sales and Growth Rate (2012-2017)
  9.1.2 Russia OTC Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Russia OTC Drug Sales Price Trend (2012-2017)
9.2 Russia OTC Drug Sales and Market Share by Manufacturers
9.3 Russia OTC Drug Sales and Market Share by Type
9.4 Russia OTC Drug Sales and Market Share by Application

10 ITALY OTC DRUG (VOLUME, VALUE AND SALES PRICE)

10.1 Italy OTC Drug Sales and Value (2012-2017)
  10.1.1 Italy OTC Drug Sales and Growth Rate (2012-2017)
  10.1.2 Italy OTC Drug Revenue and Growth Rate (2012-2017)
  10.1.3 Italy OTC Drug Sales Price Trend (2012-2017)
10.2 Italy OTC Drug Sales and Market Share by Manufacturers
10.3 Italy OTC Drug Sales and Market Share by Type
10.4 Italy OTC Drug Sales and Market Share by Application

11 SPAIN OTC DRUG (VOLUME, VALUE AND SALES PRICE)

11.1 Spain OTC Drug Sales and Value (2012-2017)
  11.1.1 Spain OTC Drug Sales and Growth Rate (2012-2017)
  11.1.2 Spain OTC Drug Revenue and Growth Rate (2012-2017)
  11.1.3 Spain OTC Drug Sales Price Trend (2012-2017)
11.2 Spain OTC Drug Sales and Market Share by Manufacturers
11.3 Spain OTC Drug Sales and Market Share by Type
11.4 Spain OTC Drug Sales and Market Share by Application

12 BENELUX OTC DRUG (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux OTC Drug Sales and Value (2012-2017)
  12.1.1 Benelux OTC Drug Sales and Growth Rate (2012-2017)
  12.1.2 Benelux OTC Drug Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux OTC Drug Sales Price Trend (2012-2017)
12.2 Benelux OTC Drug Sales and Market Share by Manufacturers
12.3 Benelux OTC Drug Sales and Market Share by Type
12.4 Benelux OTC Drug Sales and Market Share by Application

13 EUROPE OTC DRUG MANUFACTURERS ANALYSIS

13.1 Bayer HealthCare
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 GlaxoSmithKline (GSK)
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Johnson&Johnson
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Pfizer
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Sanofi
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 AstraZeneca
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 BioGaia
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Bristol Myers Squibb
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Bukwang Pharmaceutica
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE OTC DRUG MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe OTC Drug Market Forecast by Type (2017-2021)
15.9 Europe OTC Drug Market Forecast by Application (2017-2021)

16 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of OTC Drug
Table Classification of OTC Drug
Figure Europe Sales Market Share of OTC Drug by Type in 2015
Table Application of OTC Drug
Figure Europe Sales Market Share of OTC Drug by Application in 2015
Figure Germany OTC Drug Revenue and Growth Rate (2012-2021)
Figure France OTC Drug Revenue and Growth Rate (2012-2021)
Figure UK OTC Drug Revenue and Growth Rate (2012-2021)
Figure Russia OTC Drug Revenue and Growth Rate (2012-2021)
Figure Italy OTC Drug Revenue and Growth Rate (2012-2021)
Figure Spain OTC Drug Revenue and Growth Rate (2012-2021)
Figure Benelux OTC Drug Revenue and Growth Rate (2012-2021)
Figure Europe OTC Drug Sales and Growth Rate (2012-2021)
Figure Europe OTC Drug Revenue and Growth Rate (2012-2021)
Table Europe OTC Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe OTC Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 OTC Drug Sales Share by Manufacturers
Figure 2016 OTC Drug Sales Share by Manufacturers
Table Europe OTC Drug Revenue by Manufacturers (2015 and 2016)
Table Europe OTC Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe OTC Drug Revenue Share by Manufacturers
Table 2016 Europe OTC Drug Revenue Share by Manufacturers
Table Europe OTC Drug Sales and Market Share by Type (2012-2017)
Table Europe OTC Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of OTC Drug by Type (2012-2017)
Figure Europe OTC Drug Sales Growth Rate by Type (2012-2017)
Table Europe OTC Drug Revenue and Market Share by Type (2012-2017)
Table Europe OTC Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of OTC Drug by Type (2012-2017)
Figure Europe OTC Drug Revenue Growth Rate by Type (2012-2017)
Table Europe OTC Drug Sales and Market Share by Countries (2012-2017)
Table Europe OTC Drug Sales Share by Countries (2012-2017)
Figure Sales Market Share of OTC Drug by Countries (2012-2017)
Table Europe OTC Drug Revenue and Market Share by Countries (2012-2017)
Table Europe OTC Drug Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of OTC Drug by Countries (2012-2017)
Table Europe OTC Drug Sales and Market Share by Application (2012-2017)
Table Europe OTC Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of OTC Drug by Application (2012-2017)
Figure Germany OTC Drug Sales and Growth Rate (2012-2017)
Figure Germany OTC Drug Revenue and Growth Rate (2012-2017)
Figure Germany OTC Drug Sales Price Trend (2012-2017)
Table Germany OTC Drug Sales by Manufacturers (2015 and 2016)
Table Germany OTC Drug Market Share by Manufacturers (2015 and 2016)
Table Germany OTC Drug Sales by Type (2015 and 2016)
Table Germany OTC Drug Market Share by Type (2015 and 2016)
Table Germany OTC Drug Sales by Application (2015 and 2016)
Table Germany OTC Drug Market Share by Application (2015 and 2016)
Figure France OTC Drug Sales and Growth Rate (2012-2017)
Figure France OTC Drug Revenue and Growth Rate (2012-2017)
Figure France OTC Drug Sales Price Trend (2012-2017)
Table France OTC Drug Sales by Manufacturers (2015 and 2016)
Table France OTC Drug Market Share by Manufacturers (2015 and 2016)
Table France OTC Drug Sales by Type (2015 and 2016)
Table France OTC Drug Market Share by Type (2015 and 2016)
Table France OTC Drug Sales by Application (2015 and 2016)
Table France OTC Drug Market Share by Application (2015 and 2016)
Figure UK OTC Drug Sales and Growth Rate (2012-2017)
Figure UK OTC Drug Revenue and Growth Rate (2012-2017)
Figure UK OTC Drug Sales Price Trend (2012-2017)
Table UK OTC Drug Sales by Manufacturers (2015 and 2016)
Table UK OTC Drug Market Share by Manufacturers (2015 and 2016)
Table UK OTC Drug Sales by Type (2015 and 2016)
Table UK OTC Drug Market Share by Type (2015 and 2016)
Table UK OTC Drug Sales by Application (2015 and 2016)
Table UK OTC Drug Market Share by Application (2015 and 2016)
Figure Russia OTC Drug Sales and Growth Rate (2012-2017)
Figure Russia OTC Drug Revenue and Growth Rate (2012-2017)
Figure Russia OTC Drug Sales Price Trend (2012-2017)
Table Russia OTC Drug Sales by Manufacturers (2015 and 2016)
Table Russia OTC Drug Market Share by Manufacturers (2015 and 2016)
Table Russia OTC Drug Sales by Type (2015 and 2016)
Table Russia OTC Drug Market Share by Type (2015 and 2016)
Table Russia OTC Drug Sales by Application (2015 and 2016)
Table Russia OTC Drug Market Share by Application (2015 and 2016)
Figure Italy OTC Drug Sales and Growth Rate (2012-2017)
Figure Italy OTC Drug Revenue and Growth Rate (2012-2017)
Figure Italy OTC Drug Sales Price Trend (2012-2017)
Table Italy OTC Drug Sales by Manufacturers (2015 and 2016)
Table Italy OTC Drug Market Share by Manufacturers (2015 and 2016)
Table Italy OTC Drug Sales by Type (2015 and 2016)
Table Italy OTC Drug Market Share by Type (2015 and 2016)
Table Italy OTC Drug Sales by Application (2015 and 2016)
Table Italy OTC Drug Market Share by Application (2015 and 2016)
Figure Spain OTC Drug Sales and Growth Rate (2012-2017)
Figure Spain OTC Drug Revenue and Growth Rate (2012-2017)
Figure Spain OTC Drug Sales Price Trend (2012-2017)
Table Spain OTC Drug Sales by Manufacturers (2015 and 2016)
Table Spain OTC Drug Market Share by Manufacturers (2015 and 2016)
Table Spain OTC Drug Sales by Type (2015 and 2016)
Table Spain OTC Drug Market Share by Type (2015 and 2016)
Table Spain OTC Drug Sales by Application (2015 and 2016)
Table Spain OTC Drug Market Share by Application (2015 and 2016)
Figure Benelux OTC Drug Sales and Growth Rate (2012-2017)
Figure Benelux OTC Drug Revenue and Growth Rate (2012-2017)
Figure Benelux OTC Drug Sales Price Trend (2012-2017)
Table Benelux OTC Drug Sales by Manufacturers (2015 and 2016)
Table Benelux OTC Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux OTC Drug Sales by Type (2015 and 2016)
Table Benelux OTC Drug Market Share by Type (2015 and 2016)
Table Benelux OTC Drug Sales by Application (2015 and 2016)
Table Benelux OTC Drug Market Share by Application (2015 and 2016)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer HealthCare OTC Drug Sales Market Share (2012-2017)
Table GlaxoSmithKline (GSK) Basic Information List
Table GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline (GSK) OTC Drug Sales Market Share (2012-2017)
Table Johnson&Johnson Basic Information List
Table Johnson&Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson&Johnson OTC Drug Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer OTC Drug Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi OTC Drug Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca OTC Drug Sales Market Share (2012-2017)
Table BioGaia Basic Information List
Table BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure BioGaia OTC Drug Sales Market Share (2012-2017)
Table Bristol Myers Squibb Basic Information List
Table Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bristol Myers Squibb OTC Drug Sales Market Share (2012-2017)
Table Bukwang Pharmaceutica Basic Information List
Table Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bukwang Pharmaceutica OTC Drug Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of OTC Drug
Figure Manufacturing Process Analysis of OTC Drug
Figure OTC Drug Industrial Chain Analysis
Table Raw Materials Sources of OTC Drug Major Manufacturers in 2015
Table Major Buyers of OTC Drug
Table Distributors/Traders List
Figure Germany OTC Drug Sales and Growth Rate Forecast (2017-2021)
Figure Germany OTC Drug Revenue and Growth Rate Forecast (2017-2021)
Figure France OTC Drug Sales and Growth Rate Forecast (2017-2021)
Figure France OTC Drug Revenue and Growth Rate Forecast (2017-2021)
Figure UK OTC Drug Sales and Growth Rate Forecast (2017-2021)
Figure UK OTC Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Russia OTC Drug Sales and Growth Rate Forecast (2017-2021)
Figure Russia OTC Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Italy OTC Drug Sales and Growth Rate Forecast (2017-2021)
Figure Italy OTC Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Spain OTC Drug Sales and Growth Rate Forecast (2017-2021)
Figure Spain OTC Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux OTC Drug Sales and Growth Rate Forecast (2017-2021)
Figure Benelux OTC Drug Revenue and Growth Rate Forecast (2017-2021)
Table Europe OTC Drug Sales Forecast by Type (2017-2021)
Table Europe OTC Drug Sales Forecast by Application (2017-2021)


More Publications